A UCLA-led study has found that using three-dimensional virtual reality (VR) models to prepare for kidney tumor surgeries resulted in substantial improvements, including shorter operating times, less blood loss during surgery and a shorter stay in the hospital afterward.

Siemens Healthineers and national nonprofit HealthyWomen announced results from a new national survey designed to deepen understanding on how to improve women’s experiences with screening mammograms for breast cancer detection. The survey, which included responses from women over age 40 (all of whom fall under the recommended screening guidelines), revealed that while 61 percent of women said mammograms are necessary, 52 percent found them uncomfortable and 25 percent regarded them as painful.

Fujifilm SonoSite Inc. and the Allen Institute of Artificial Intelligence (AI2) Incubator, builder of AI-first startups, announced a collaboration to interpret ultrasound images with AI, enabling new ultrasound applications and enhanced accuracy. Fujifilm SonoSite has enlisted assistance from the AI2 Incubator to deploy deep learning models on portable ultrasound products. Together, the AI2 Incubator and Fujifilm SonoSite will work to improve image analysis, allowing for the interpretation of a much wider range of ultrasound scenarios.

If researchers could observe drug delivery and its effect on cancer cells in real time, they would be able to tailor treatment options with unprecedented specificity.

Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago. Featured introductions included PositionPro, a new pitch and roll correction-enabled immobilization system for cranial and head and neck radiotherapy treatments, a new line of thermoplastics and a strapless Respiratory Compression Belt.

Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a landmark study published in the journal Radiology.

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer (NSCLC), increasing progression-free survival (PFS). Findings of the phase II randomized trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago.

The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary syndromes (CCS), which classifies computed tomography angiography (CTA) as a Class 1 recommendation for diagnosing CAD in symptomatic patients. The document, which is a continuation of the 2013 stable coronary artery disease (CAD) guidelines, updates the term to CCS to emphasize the dynamic nature of the disease. It was released at the 2019 ESC Congress, Aug. 31-Sept. 4 in Paris, France, and published simultaneously in the European Heart Journal.